• BMX-IN-1: From BMX Signaling to Host Defense

  2026-09-04

  A translational perspective on BMX-IN-1 that connects covalent BMX kinase inhibition with cancer biology, lysosomal acidification, and host-directed tuberculosis research while emphasizing experimental controls, assay design, and the limits of current evidence.

• PF-573228 FAK Inhibitor: Mechanobiology Workflows

  2026-09-04

  Use PF-573228 to test whether focal adhesion kinase links matrix mechanics to dentinogenesis, cancer-cell behavior, or endothelial angiogenic responses. This guide combines stiffness-aware controls, phospho-FAK validation, practical dosing, and troubleshooting for more interpretable results.

• KNUCKLES Controls Floral Meristem Termination

  2026-09-03

  The reference study shows that KNUCKLES terminates the Arabidopsis floral meristem by coordinating chromatin repression of PIN1 and IPT7 with the established WUS–CLV3 stem-cell circuit. Its findings connect auxin distribution and cytokinin activity to the timing of floral determinacy, offering a more integrated model of how a proliferative meristem becomes a defined floral structure.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-03

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for controlled studies of glucocorticoid access, corticosterone metabolism, and gap junction communication. It is best used in cell- and tissue-based mechanistic workflows with solvent, viability, and pathway controls, not as a selective treatment or validated efficacy agent for in vivo disease models.

• IL-1β, NF-κB, and Macrophage ACE2

  2026-09-02

  Lee et al. developed a humanized ACE2 mouse that preserves native Ace2-locus regulation and used it to examine SARS-CoV-2 infection in macrophages. Their findings connect IL-1β-driven NF-κB activity with dynamic ACE2 induction, providing a mechanistic explanation for macrophage susceptibility while distinguishing a resilient disease model from the severe K18-hACE2 phenotype.

• Fumagillin: Mechanism to Translational Strategy

  2026-09-02

  A mechanism-first guide to using Fumagillin in angiogenesis, cancer, and exploratory antiparasitic research while separating target biology, assay conditions, formulation, and translational evidence.

• TMEM16F, Ferroptosis, and Tumor Immune Rejection

  2026-09-01

  Yang et al. identify TMEM16F-mediated plasma-membrane lipid scrambling as a late-stage suppressor of ferroptosis. The study links failed membrane remodeling to lytic death, danger-signal release, slower tumor growth, and improved response to PD-1 blockade, providing a mechanistic bridge between ferroptosis execution and antitumor immunity.

• Tioconazole Workflows for Antifungal Research

  2026-09-01

  Build reproducible antifungal assays around Tioconazole by controlling solvent, exposure time, fungal growth state, and orthogonal readouts. This practical guide also shows how energy-state controls inspired by recent DNA-repair research can strengthen interpretation without overstating cross-domain evidence.

• Cl-Amidine: A PAD4 Perturbation Map for AML

  2026-08-31

  Cl-Amidine trifluoroacetate salt provides a focused way to test how PAD4-dependent histone citrullination intersects with AML transcriptional circuitry. This article translates the LMO2/LDB1 study into a practical, layered assay strategy while defining what Cl-Amidine can—and cannot—demonstrate.

• EZ Cap™ Firefly Luciferase mRNA: Assay Guide

  2026-08-31

  Learn how EZ Cap™ Firefly Luciferase mRNA (5-moUTP), SKU R1013, can improve the interpretability of cell viability, proliferation, and cytotoxicity workflows. This scenario-driven guide covers transcript design, delivery compatibility, handling, controls, data interpretation, and practical vendor selection.

• BMX-IN-1: From Kinase Control to Host Defense

  2026-08-30

  A translational perspective on BMX-IN-1 as an irreversible BMX kinase inhibitor for connecting kinase signaling with lysosomal acidification, cancer biology, and host-directed tuberculosis research.

• ASCH Proteins and N4-Acetylcytidine Processing

  2026-08-29

  Meng et al. define how the ASCH-domain enzyme EcYqfB hydrolyzes free N4-acetylcytidine to cytidine while showing that it does not remove ac4C from cellular RNA. Comparative structures of EcYqfB, mouse EOLA1, and the human TRIP4-ASCH domain reveal that related ASCH proteins can have distinct substrate preferences, an important consideration for RNA modification and nucleotide-processing studies.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-08-28

  Sulfo-NHS-LC-Biotin is a water-soluble reagent for stable biotinylation of primary amines on proteins, peptides, and accessible cell-surface proteins. It is suited to downstream biotin-avidin detection or streptavidin resin capture, but not to intracellular or reversible labeling workflows.

• Leucomycin (Kitasamycin) Assay Workflows

  2026-08-28

  Build more reliable MIC, translational inhibition, and macrolide resistance studies with Leucomycin while accounting for its multicomponent composition and solvent limitations. An analytical workflow adapted from HPLC-CAD to UV detection adds a practical quality-control layer for potency comparisons and degradation monitoring.

• Indomethacin Workflows for Inflammation Research

  2026-08-27

  Indomethacin offers a practical way to separate cyclooxygenase inhibition from PPAR-linked adipocyte effects and membrane-state changes in research assays. This workflow translates beige-fat thermogenesis findings into controlled inflammation research, lipid metabolism study, and membrane signaling modulation experiments.

7627 records 1/509 page Next 12345 下5页 Last page